Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study

J Crit Care. 2021 Apr:62:111-116. doi: 10.1016/j.jcrc.2020.12.001. Epub 2020 Dec 8.

Abstract

Purpose: This study aims to describe differences in shock reversal between hydrocortisone 200 mg and 300 mg per day dosing regimens in patients with septic shock.

Methods: This is a multi-center retrospective study including patients admitted to intensive care units with septic shock receiving vasopressors and hydrocortisone between 2013 and 2018. We compared patients who received low dose hydrocortisone (50 mg every 6 h) versus high dose hydrocortisone (100 mg every 8 h) on the primary outcome of shock reversal.

Results: 319 patients (low dose group, n = 134 and high dose group, n = 185) were included. In the multivariate regression model, high-dose steroids were associated with shock reversal [OR (95% CI) = 2.278 (1.063-4.880), p = 0.034]. This was not confirmed in the propensity score matched analysis [OR (95% CI) =2.202 (0.892-5.437), p = 0.087]. High dose steroids were associated with a lower need for additional vasopressor therapy (22% vs. 34%, p = 0.012) and lower shock recurrence (6.7% vs. 16%, p = 0.013), which was confirmed with propensity score matching.

Conclusions: Low and high dose hydrocortisone have similar rates of shock reversal in septic shock patients. Hydrocortisone 100 mg every 8 h may reduce rates of recurrence of shock and reduce the need for additional vasopressors.

Keywords: Corticosteroids; Hydrocortisone; Intensive care unit; Sepsis; Septic shock; Shock recurrence; Vasopressors.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Humans
  • Hydrocortisone* / therapeutic use
  • Intensive Care Units
  • Retrospective Studies
  • Shock, Septic* / drug therapy

Substances

  • Anti-Inflammatory Agents
  • Hydrocortisone